Dr Savidge noted Dr Hill's view that continued use of the same batch confined the risk of infectivity but it was not practised on Johnathan Buggins. Between 1981 and mid-1984, he had been exposed to 20 different batches of Armour factor VIII. Read more about Dr Savidge noted Dr Hill's view that continued use of the same batch confined the risk of infectivity but it was not practised on Johnathan Buggins. Between 1981 and mid-1984, he had been exposed to 20 different batches of Armour factor VIII.
Dr Savidge stated Armour concentrate was used exclusively in 1983 and 1984 with no reference to the available NHS concentrate at the hospital. Read more about Dr Savidge stated Armour concentrate was used exclusively in 1983 and 1984 with no reference to the available NHS concentrate at the hospital.
Dr Savidge stated the administration of a large donor pool of commercial material in preference to cryoprecipitate without authorisation was negligent. Read more about Dr Savidge stated the administration of a large donor pool of commercial material in preference to cryoprecipitate without authorisation was negligent.
Medical Report and Opinion was prepared regarding the treatment of Jonathan Buggins by G. F. Savidge Read more about Medical Report and Opinion was prepared regarding the treatment of Jonathan Buggins by G. F. Savidge
Dr Mounir Wassef wrote to Dr Hill, outlining that one of his patents was exhibiting AIDS stigmata. Read more about Dr Mounir Wassef wrote to Dr Hill, outlining that one of his patents was exhibiting AIDS stigmata.
Minutes of the West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs where there was reported to be an excess of cryoprecipitate. This was potentially attributed to overstocking in anticipation of a reduced supply of Factor VIII concentrate from BPL. Read more about Minutes of the West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs where there was reported to be an excess of cryoprecipitate. This was potentially attributed to overstocking in anticipation of a reduced supply of Factor VIII concentrate from BPL.
Minutes of the West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs where it was recommended that during the next 6 months all Centres should cut down on the use of Factor VIII and increase their usage of cryoprecipitate. Members agreed any shortfall would have to be met by increased purchasing of Commercial Factor VIII. Read more about Minutes of the West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs where it was recommended that during the next 6 months all Centres should cut down on the use of Factor VIII and increase their usage of cryoprecipitate. Members agreed any shortfall would have to be met by increased purchasing of Commercial Factor VIII.
Minutes of the West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs which agreed to recommend to Dr Ala, the regional transfusion director, that NHS concentrate should be distributed in proportion to the number of patients treated. Read more about Minutes of the West Midlands Regional Health Authority Working Party on the Treatment of Haemophiliacs which agreed to recommend to Dr Ala, the regional transfusion director, that NHS concentrate should be distributed in proportion to the number of patients treated.
Report on case for an additional Haemophilia Sister which outlined the increase in haemophilia workload annually and the number of sisters working at the Queen Elizabeth Hospital and Birmingham Children's Hospital. Read more about Report on case for an additional Haemophilia Sister which outlined the increase in haemophilia workload annually and the number of sisters working at the Queen Elizabeth Hospital and Birmingham Children's Hospital.
Annual Returns for Birmingham Children's Hospital 1984 recorded a very modest increase in the amount of cryoprecipitate used and an increase in NHS concentrate. Read more about Annual Returns for Birmingham Children's Hospital 1984 recorded a very modest increase in the amount of cryoprecipitate used and an increase in NHS concentrate.